The increased estrogen receptor expression in thymocytes and PBMCs in patients with MG induced by the inflammatory environment suggests that estrogens potentially contribute to the MG autoimmune process by affecting cytokine production and B cell activity (29, 110). Here, ESR1 is linked to myasthenia gravis.